IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2a biotech developing therapies for neuronal excitability disorders.
Industry: Health Care
Latest Trade: $3.52 +0.13 (+3.8%)
First Day Return: +27.2%
Return from IPO: -72.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/16/2021 |
Offer Price | $12.50 |
Price Range $12.50 - $12.50 | |
Offer Shares (mm) | 6.4 |
Deal Size ($mm) | $80 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/09/2021 |
Offer Price | $12.50 |
Price Range $12.50 - $12.50 | |
Offer Shares (mm) | 6.4 |
Deal Size ($mm) | $80 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Leerink Partners |
Evercore ISI |
more |
Company Data | |
---|---|
Headquarters | Redmond, WA, United States |
Founded | 2018 |
Employees | 22 |
Website www.eliemtx.com |